“Treat to Target” for Lipid Management: Optimizing Clinical Care and Primary Prevention for High-Risk Patients
Join CHCANYS and Dr. Natalie Levy, Medical Director of Bellevue’s Primary Care Chronic Disease Management Programs, inclusive of the Primary Care Diabetes and Hypertension Programs, as well as your health center colleagues from ConnextCare and Ryan Health for an illuminating discussion about lipid management and the importance of leveraging a “treat to target” framework to support primary prevention, continuity of care, and shared-decision making among high-risk patients.
Review the latest evidence-based guidelines and strategies for successful implementation in clinical practice in support of team-based workflows, patient engagement, and medication adherence. Learn how to advance statin therapy prescribing efforts and support a “treat to target” framework leveraging a multi-disciplinary clinical care team, ideal workflows and processes.
The session will address the following objectives:
Review of the AHA/ACC LDL Goals for the Primary Prevention of ASCVD.
The landscape of statin intolerance among CHC patient populations.
Alternatives and related barriers or facilitators to statins (i.e., PCSK9 inhibitors, bempedoic acid, oral vs. injectable options).
The role of multi-disciplinary clinical care teams in supporting a “treat to target” framework for optimal cholesterol management and shared decision-making among high-risk patients.